Methods for treating active eosinophilic esophagitis
US11053309B2 · kind B2 · utility
10Cited by
40References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 3, 2018 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Aug 3, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating, preventing or reducing the severity of active eosinophilic esophagitis. In certain embodiments, the present invention provides methods of increasing esophageal distensibility. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4/interleukin-13 (IL-4/IL-13) pathway inhibitor such as an anti-IL-4R antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.